retatrutide triple agonist glp-1 gip glucagon receptor Medscape | The investigational GLP-1/GIP/glucagon produced significant weight loss and A1c reduction in people Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Pay in 4 interest-free payments of $7.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24






















